Expression of σ receptors of human urinary bladder tumor cells (RT-4 cells) and development of a competitive receptor binding assay for the determination of ligand affinity to human σ2 receptors

Journal of Pharmaceutical and Biomedical Analysis

Volumn 55, Issue 5, 2011, Pages 1136-1141

  Schepmann, Dirk ^a   Lehmkuhl, Kirstin ^a   Brune, Stefanie ^a   Wünsch, Bernhard ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

2 receptor binding assay; Human 2 receptor; RT 4 cells; Saturation experiments

Indexed keywords

ALPHA (4 FLUOROPHENYL) 4 (5 FLUORO 2 PYRIMIDINYL) 1 PIPERAZINEBUTANOL; HALOPERIDOL; PENTAZOCINE; RADIOLIGAND;

ANIMAL EXPERIMENT; ARTICLE; BINDING ASSAY; BLADDER TUMOR; CELL MEMBRANE; HOMOGENATE; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TUMOR CELL;

ANIMALS; BINDING, COMPETITIVE; CELL MEMBRANE; CHEMISTRY TECHNIQUES, ANALYTICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KINETICS; LIGANDS; LIVER; MODELS, CHEMICAL; PENTAZOCINE; RATS; RECEPTORS, SIGMA; TEMPERATURE; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 79956138579     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2011.03.044     Document Type: Article

References (34)

1. Martin W.R., Eades C.G., Thompson J.A., Huppler R.E., Gilbert P.E. The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 1976, 197:517-532.
2. Quirion R., Bowen W.D., Itzhak Y., Junien J.L., Musacchio J.M., Rothman R.B., Su T.P., Tam S.W., Taylor D.P. A proposal for the classification of sigma binding sites. Trends Pharmacol. Sci. 1992, 13:85-86.
3. Booth R.G., Owens C.E., Brown R.L., Bucholtz E.C., Lawler C.P., Wyrick S.D. Putative sigma(3) sites in mammalian brain have histamine H(1) receptor properties: evidence from ligand binding and distribution studies with the novel H(1) radioligand [(3)H]-(-)-trans-1-phenyl-3-aminotetralin. Brain Res. 1999, 837:95-105.
4. Myers A.M., Charifson P.S., Owens C.E., Kula N.S., McPhail A.T., Baldessarini R.J., Booth R.G., Wyrick S.D. Conformational analysis, pharmacophore identification, and comparative molecular field analysis of ligands for the neuromodulatory sigma 3 receptor. J. Med. Chem. 1994, 37:4109-4117.
5. Hanner M., Moebius F.F., Flandorfer A., Knaus H.G., Striessnig J., Kempner E., Glossmann H. Purification, molecular cloning, and expression of the mammalian sigma1-binding site. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:8072-8077.
6. Kekuda R., Prasad P.D., Fei Y.J., Leibach F.H., Ganapathy V. Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1). Biochem. Biophys. Res. Commun. 1996, 229:553-558.
7. Seth P., Fei Y.J., Li H.W., Huang W., Leibach F.H., Ganapathy V. Cloning and functional characterization of a sigma receptor from rat brain. J. Neurochem. 1998, 70:922-931.
8. Prasad P.D., Li H.W., Fei Y.J., Ganapathy M.E., Fujita T., Plumley L.H., Yang-Feng T.L., Leibach F.H., Ganapathy V. Exon-intron structure, analysis of promoter region, and chromosomal localization of the human type 1 sigma receptor gene. J. Neurochem. 1998, 70:443-451.
9. Ramamoorthy J.D., Ramamoorthy S., Mahesh V.B., Leibach F.H., Ganapathy V. Cocaine-sensitive sigma-receptor and its interaction with steroid hormones in the human placental syncytiotrophoblast and in choriocarcinoma cells. Endocrinology 1995, 136:924-932.
10. Su T.P., London E.D., Jaffe J.H. Steroid binding at sigma-receptors suggests a link between endocrine, nervous, and immune-systems. Science 1988, 240:219-221.
11. Fontanilla D, Johannessen M., Hajipour A.R., Cozzi N.V., Jackson M.B., Ruoho A.E. The hallucinogen N,N-Dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator. Science 2009, 323:934-937.
12. Hellewell S.B., Bruce A., Feinstein G., Orringer J., Williams W., Bowen W.D. Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling. Eur. J. Pharmacol. 1994, 268:9-18.
13. Aydar E., Onganer P., Perrett R., Djamgoz M.B., Palmer C.P. The expression and functional characterization of sigma (sigma) 1 receptors in breast cancer cell lines. Cancer Lett. 2006, 242:245-257.
14. Langa F., Codony X., Tovar V., Lavado A., Gimenez E., Cozar P., Cantero M., Dordal A., Hernandez E., Perez R., Monroy X., Zamanillo D., Guitart X., Montoliu L. Generation and phenotypic analysis of sigma receptor type I (sigma 1) knockout mice. Eur. J. Neurosci. 2003, 18:2188-2196.
15. Walker J.M., Bowen W.D., Walker F.O., Matsumoto R.R., De Costa B., Rice K.C. Sigma receptors: biology and function. Pharmacol. Rev. 1990, 42:355-402.
16. Bem W.T., Thomas G.E., Mamone J.Y., Homan S.M., Levy B.K., Johnson F.E., Coscia C.J. Overexpression of sigma receptors in nonneural human tumors. Cancer Res. 1991, 51:6558-6562.
17. Geiger C., Zelenka C., Weigl M., Fröhlich R., Wibbeling B., Lehmkuhl K., Schepmann D., Grünert R., Bednarski P.J., Wünsch B. Synthesis of bicyclic sigma receptor ligands with cytotoxic activity. J. Med. Chem. 2007, 50:6144-6153.
18. Holl R., Schepmann D., Bednarski P.J., Grünert R., Wünsch B. Relationships between the structure of 6-substituted 6, 8-diazabicyclo [3. 2. 2]nonan-2-ones and their sigma receptor affinity and cytotoxic activity. Bioorg. Med. Chem. 2009, 17:1445-1455.
19. Holl R., Schepmann D., Froehlich R., Grünert R., Bednarski P.J., Wünsch B. Dancing of the second aromatic residue around the 6, 8-Diazabicyclo[3. 2. 2]nonane framework: influence on sigma receptor affinity and cytotoxicity. J. Med. Chem. 2009, 52:2126-2137.
20. Mach R.H., Smith C.R., Al-Nabulsi I., Whirrett B.R., Childers S.R., Wheeler K.T. Sigma 2 receptors as potential biomarkers of proliferation in breast cancer. Cancer Res. 1997, 57:156-161.
21. Vilner B.J., John C.S., Bowen W.D. Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines. Cancer Res. 1995, 55:408-413.
22. Rigby C.C., Franks L.M. A human tissue culture cell line from a transitional cell tumour of the urinary bladder: growth, chromosome pattern and ultrastructure. Br. J. Cancer 1970, 24:746-754.
23. Collier T.L., Waterhouse R.N., Kassiou M. Imaging sigma receptors: applications in drug development. Curr. Pharm. Des. 2007, 13:51-72.
24. Colabufo N.A., Abate C., Contino M., Inglese C., Niso M., Berardi F., Perrone R. PB183, a sigma receptor ligand, as a potential PET probe for the imaging of prostate adenocarcinoma. Bioorg. Med. Chem. Lett. 2008, 18:1990-1993.
25. Colabufo N.A., Berardi F., Contino M., Perrone R., Tortorella V. A new method for evaluating sigma(2) ligand activity in the isolated guinea-pig bladder, Naunyn-Schmiedeberg's. Arch. Pharmacol. 2003, 368:106-112.
26. Colabufo N.A., Berardi F., Contino M., Ferorellia S., Niso M., Perrone R., Pagliarulo A., Saponaro P., Pagliarulo V. Correlation between sigma(2) receptor protein expression and histopathologic grade in human bladder cancer. Cancer Lett. 2006, 237:83-88.
27. Maier C.A., Wünsch B. Novel spiropiperidines as highly potent and subtype selective sigma-receptor ligands. Part 1. J. Med. Chem. 2002, 45:438-448.
28. Wirt U., Schepmann D., Wünsch B. Asymmetric synthesis of 1-substituted tetrahydro-3-benzazepines as NMDA receptor antagonists. Eur. J. Org. Chem. 2007, 462-475.
29. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
30. Stoscheck C.M. Increased uniformity in the response of the coomassie blue G protein assay to different proteins. Anal. Biochem. 1990, 184:111-116.
31. Cheng Y., Prusoff W.H. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 1973, 22:3099-3108.
32. Mach R.H., Smith C.R., Childers S.R. Ibogaine possesses a selective affinity for sigma 2 receptors. Life Sci. 1995, 57:PL57-62.
33. Matsumoto R.R., Pouw B. Correlation between neuroleptic binding to sigma(1) and sigma(2) receptors and acute dystonic reactions. Eur. J. Pharmacol. 2000, 401:155-160.
34. Perregaard J., Moltzen E.K., Meier E., Sanchez C. Sigma-ligands with subnanomolar affinity and preference for the sigma(2) binding-site. 1.3-(Omega-Aminoalkyl)-1H-Indoles. J. Med. Chem. 1995, 38:1998-2008.